ATTR-CM Symptoms and Hospitalizations Improve With Acoramidis
Episode Summary
Acoramidis preserved health status and reduced cardiovascular hospitalizations in transthyretin amyloid cardiomyopathy, supporting treatment decisions that consider symptoms, daily function, quality of life, and survival.